Overexpression of BMX in androgen-sensitive LNCaP cells promotes tumor growth while knocking down BMX expression in hormone-insensitive prostate cancer cells inhibits tumor growth under androgen-depleted conditions [24]. Here, BMX is linked to prostate cancer.